Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

and no use of systemic corticosteroids for exacerbation treatment or maintenance therapy. Bradley Chipps, MD, and colleagues ...

No cases of QT interval prolongation were identified. In our cohort of patients with severe asthma and residual exacerbations despite biologics, additional azithromycin treatment resulted in a ...

The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

Improperly controlled asthma results in episodic severe exacerbations despite treatment with medium- or high-dose inhaled glucocorticoids along with additional controller medications. Increased levels ...

Nighttime asthma symptoms are also a typical sign of an asthma exacerbation. Peak expiratory flow (PEF ... Airsupra is a combination of a SABA and an inhaled corticosteroid (ICS) for the treatment of ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients with ...

The literature was reviewed to determine whether data support current treatment guideline ... in the treatment of chronic obstructive pulmonary disease (COPD) exacerbations. Summary.

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...